Webinars

FamilieSCN2A rx: Hope Table Talks

Sept 5th, 2019 Update on KCNQ2 Studies in the Channelopathy-Associated Epilepsy Research Center without Walls from KCNQ2 Cure Alliance on Vimeo.

July 24, 2019 A New Clinical Trial in KCNQ2-DEE and Upcoming Related Patient Survey from KCNQ2 Cure Alliance on Vimeo.

March 2019 Episode #6 - Epilepsy Genetics: Testing Can Make a Difference featuring Dr. John Millichap from CURE - Citizens United for Research In Epilepsy

Jan 25th, 2017 KCNB1 webinar

Listen to SCN2A Insights each month for the latest on SCN2A and genetic epilepsy

Recent Publications

Stamberger H, et al. 2022. Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood. Neurology (07 2022)

Zybura AS, et al. 2022. CaMKII Inhibition Attenuates Distinct Gain-of-Function Effects Produced by Mutant Nav1.6 Channels and Reduces Neuronal Excitability. Cells (07 2022)

Knowles JK, et al. 2022. Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress. Epilepsia (Jun 2022)

Oliver KL, et al. 2022. Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery. EBioMedicine (Jul 2022)

Hammer MF, et al. 2022. Whole exome sequencing and co-expression analysis identify an SCN1A variant that modifies pathogenicity in a family with genetic epilepsy and febrile seizures plus. Epilepsia (Aug 2022)